Literature DB >> 10150523

Relationship between AIDS and family planning programmes: a rationale for developing integrated reproductive health services.

S Pachauri1.   

Abstract

This paper examines the potential links between family planning and maternal and child health programmes and the emerging needs of the global AIDS epidemic; and assesses the feasibility of organizing comprehensive reproductive health programmes in developing countries to include the prevention and control of reproductive tract infections including sexually transmitted infections as well as HIV/AIDS. The paper discusses arguments opposing the integration of programmes against sexually transmitted infections within family planning and MCH programmes, as well as the programmatic and epidemiological reasons for considering such integration. It is important to determine what elements can be realistically integrated within programmes of varying organizational capacity without compromising their effectiveness.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--prevention and control; Delivery Of Health Care; Developing Countries; Diseases; Economic Factors; Family Planning; Family Planning Programs; Health; Hiv Infections--prevention and control; Infections; Integrated Programs; Needs; Programs; Recommendations; Reproductive Health; Reproductive Tract Infections; Sexually Transmitted Diseases--prevention and control; Viral Diseases

Mesh:

Year:  1994        PMID: 10150523

Source DB:  PubMed          Journal:  Health Transit Rev        ISSN: 1036-4005


  2 in total

1.  Impact of integrated family planning and HIV care services on contraceptive use and pregnancy outcomes: a retrospective cohort study.

Authors:  Rose J Kosgei; Kizito M Lubano; Changyu Shen; Kara K Wools-Kaloustian; Beverly S Musick; Abraham M Siika; Hillary Mabeya; E Jane Carter; Ann Mwangi; James Kiarie
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-15       Impact factor: 3.731

Review 2.  Priority strategies for India's family planning programme.

Authors:  Saroj Pachauri
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.